Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07820241
What this trial is testing

Long-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004

Who this might be right for
Human Papillomavirus Infection
Shanghai Zerun Biotechnology Co.,Ltd 348
Large-scale testing (Phase 3)Study completedNCT03239496
What this trial is testing

Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Who this might be right for
Poliomyelitis
Fidec Corporation 773
Large-scale testing (Phase 3)Looking for participantsNCT07415252
What this trial is testing

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Who this might be right for
Varicella (Chickenpox)
SK Bioscience Co., Ltd. 780
Large-scale testing (Phase 3)Study completedNCT00169507
What this trial is testing

Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)

Who this might be right for
Prophylaxis Pneumococcal Vaccine
GlaxoSmithKline 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04708041
What this trial is testing

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 700
Early research (Phase 1)Study completedNCT02052726
What this trial is testing

Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Who this might be right for
Clostridium Difficile
Pfizer 184
Not applicableStudy completedNCT01641315
What this trial is testing

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 75
Post-approval studies (Phase 4)UnknownNCT01841671
What this trial is testing

Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine

Who this might be right for
Polio
University of Chile 570
Early research (Phase 1)Study completedNCT00894114
What this trial is testing

Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 250
Early research (Phase 1)Study completedNCT00457782
What this trial is testing

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 27
Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Large-scale testing (Phase 3)Study completedNCT01310400
What this trial is testing

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

Who this might be right for
Influenza
Crucell Holland BV 1,356
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991738
What this trial is testing

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Who this might be right for
Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Large-scale testing (Phase 3)Study completedNCT05431933
What this trial is testing

Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

Who this might be right for
PoliomyelitisVaccine Reaction
LG Chem 2,001
Testing effectiveness (Phase 2)Study completedNCT03607916
What this trial is testing

Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery.

Who this might be right for
Pregnant Women
Centre Hospitalier Universitaire Saint Pierre 40
Early research (Phase 1)Study completedNCT01967043
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
Kinex Pharmaceuticals Inc. 34
Early research (Phase 1)UnknownNCT02963168
What this trial is testing

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

Who this might be right for
Solid Tumor
Athenex, Inc. 24
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Large-scale testing (Phase 3)Study completedNCT00697554
What this trial is testing

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age

Who this might be right for
Hepatitis B
GlaxoSmithKline 93
Next Page